COMP <GO>
LQDA vs MRK // DIVIDEND YIELD & FCF PAYOUT SAFETY
Liquidia Corporation (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: LQDA 2
— MRK 11
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: MRK
LAST: $45.06 (+0.16%) • MKT CAP: $4.03B
dividend-safety
0.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
dividend-safety
2.26%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDA VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDA | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.60% | 20.70% | -33.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.99% | 3.42% | -4.41 | MRK | /fcf-yield <GO> |
| Operating Margin | -32.50% | 34.30% | -66.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | -43.50% | 28.10% | -71.60 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 1.30% | +178.70 | LQDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.33 | 5.19 | +1.14 | LQDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 56.9 | -4.33 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.92 | -0.02 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 18.4x | +2.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.03B | $361.02B | -$356.99B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDA REV | MRK REV | LQDA GROSS % | MRK GROSS % | LQDA FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.3M | $65.01B | 44.0% | 74.8% | -$40.0M | $12.36B |
| FY 2024 | $14.0M | $64.17B | 58.0% | 76.3% | -$98.4M | $18.10B |
| FY 2023 | $17.5M | $60.12B | 44.0% | 44.0% | -$42.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDA // BETA 0.90
MRK // BETA 0.92